DMPK & Safety Assessment
In Vivo DMPK & Safety Assessment
With over 30 years of experience, Pharmacology Discovery Services provides in vivo DMPK & Safety assessment models in order to understand the physicochemical properties and risk profile for drug candidate(s). Our highly-experienced team of Technical Directors, Study Directors, Scientific & Operational Teams will work with you to develop a dosing and sample collection strategy that will provide the data you need to better interpret efficacy and toxicology results. We also offer qualified safety related in vivo models to detect the most commonly observed adverse events in a number of different therapeutic areas. Our team of highly-experienced experts can assist with your in vivo DMPK & Safety studies so you may receive the critical information you need in your drug discovery program.
In Vitro Products & Services for Drug Discovery
Pharmacology Discovery Services is a Partner Lab of Eurofins Pharma Discovery Services. For >40 years, Eurofins Pharma Discovery Services has been a trusted CRO supporting global Drug Discovery clients from Target ID through to Candidate Selection. Eurofins Pharma Discovery Services was built by bringing together the market leading drug discovery expertise of Panlabs, Cerep, EMD Millipore's Discovery & Development Solutions business, and Villapharma Research.
Available in vitro DMPK & Safety services include over 150 ADME-Tox assays and an in vitro safety pharmacology portfolio that includes thousands of assays. Additional services include cell-based phenotypic assays, safety & efficacy, chemistry and custom proteins & assay development services. This partnership grants our clients access to a broad portfolio of drug discovery products and services to help advance their drug candidates to the clinic.